Brief Information of the Cell Line and Protein
Cell Line ID: CL000186 , RPMI-8226
Synonyms
RPMI 8226
RPMI.8226
RPMI8226
RPMI no. 8226
RPMI no 8226
RPMI #8226
8226
RPMI 8226/S
RPMI-8226S
RPMI8226/S
8226/S
Roswell Park Memorial Institute 8226
GM02132
GM2132
GM 2132
GM02132C
Simpson
Category Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_0014
Protein ID: PT03838 , Proteasome subunit beta type-9
Gene Name PSMB9
Organism Homo sapiens, Human
Protein Classification Enzyme
Uniprot ID P28065
Table of Molecular Bioactivities Related to the Cell Line and Protein
Cell Line ID: CL000186  Protein ID: PT03838
 
Compound ID Compound Name Compound Formula
CP0958942
N-((2S)-3-hydroxy-1-((2S)-1-hydroxy-1-((R)-2-methyloxiran-2-yl)-3-phenylpropan-2-ylamino)-1-oxopropan-2-yl)-6-oxo-1,6-dihydropyridine-2-carboxamide
   Show/Hide
C21H25N3O6
 2
1
IC50 = 28 nM
   TI
   LI
   LO
   TS
2
IC50 = 204.4 nM
   TI
   LI
   LO
   TS
CP0075994
(2S)-1-(2-acetamidoacetyl)-N-[(2S)-1-[[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]pyrrolidine-2-carboxamide
   Show/Hide
C27H38N4O6
 2
1
IC50 = 30.9 nM
   TI
   LI
   LO
   TS
2
IC50 = 213 nM
   TI
   LI
   LO
   TS
CP0418920
(3S,6S)-N-[(2S)-1-[(2R)-2-methyloxiran-2-yl]-1-oxo-3-phenylpropan-2-yl]-5,11-dioxo-19-oxa-4,10-diazatricyclo[18.2.2.06,10]tetracosa-1(23),20(24),21-triene-3-carboxamide
   Show/Hide
C34H43N3O6
 2
1
IC50 = 32.7 nM
   TI
   LI
   LO
   TS
2
IC50 = 105.6 nM
   TI
   LI
   LO
   TS
CP0576198
(3S,6S)-N-[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]-5,11-dioxo-19-oxa-4,10-diazatricyclo[18.2.2.06,10]tetracosa-1(23),20(24),21-triene-3-carboxamide
   Show/Hide
C31H45N3O6
 2
1
IC50 = 33.9 nM
   TI
   LI
   LO
   TS
2
IC50 = 160.7 nM
   TI
   LI
   LO
   TS
CP0573254
(10S,13S)-N-[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]-2,12-dioxo-8-oxa-1,11-diazabicyclo[11.3.0]hexadecane-10-carboxamide
   Show/Hide
C23H37N3O6
 2
1
IC50 = 35.8 nM
   TI
   LI
   LO
   TS
2
IC50 = 146.8 nM
   TI
   LI
   LO
   TS
CP0475672
(2S)-1-[(2S)-2-[(2-azidoacetyl)amino]propanoyl]-N-[(2S)-1-[[(2S)-3-cyclohexyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]-4,4-difluoropyrrolidine-2-carboxamide
   Show/Hide
C28H43F2N7O6
 1
1
IC50 = 130 nM
   TI
   LI
   LO
   TS
CP0399509
(2S)-1-[(2S)-2-[(2-azidoacetyl)amino]propanoyl]-N-[(2S)-1-[[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]pyrrolidine-2-carboxamide
   Show/Hide
C25H41N7O6
 1
1
IC50 = 140 nM
   TI
   LI
   LO
   TS
CP0062987
(2S)-3-(4-methoxyphenyl)-N-[(2S)-1-[(2R)-2-methyloxiran-2-yl]-1-oxo-3-phenylpropan-2-yl]-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide
   Show/Hide
C31H40N4O7
 1
1
IC50 = 340 nM
   TI
   LI
   LO
   TS
CP0885679
(S)-N-((S)-3-cyclohexyl-1-((R)-2-methyloxiran-2-yl)-1-oxopropan-2-yl)-3-(4-methoxyphenyl)-2-((S)-2-(2-morpholinoacetamido)propanamido)propanamide
   Show/Hide
C31H46N4O7
 1
1
IC50 = 370 nM
   TI
   LI
   LO
   TS
CP0847941
N-((R)-1-((S)-3-(1H-indol-3-yl)-1-((S)-1-((R)-2-methyloxiran-2-yl)-1-oxo-3-phenylpropan-2-ylamino)-1-oxopropan-2-ylamino)-1-oxopropan-2-yl)-3-methyl-1H-indene-2-carboxamide
   Show/Hide
C37H38N4O5
 1
1
IC50 = 3500 nM
   TI
   LI
   LO
   TS
CP0864816
(S)-N-((S)-3-cyclohexyl-1-((R)-2-methyloxiran-2-yl)-1-oxopropan-2-yl)-3-(1H-indol-3-yl)-2-((R)-2-(2-morpholinoacetamido)propanamido)propanamide
   Show/Hide
C32H45N5O6
 1
1
IC50 = 6200 nM
   TI
   LI
   LO
   TS
CP0386861
(2S)-N-[(2S)-3-cyclohexyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-(4-methoxyphenyl)-2-[[(2R)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide
   Show/Hide
C31H46N4O7
 1
1
IC50 = 7300 nM
   TI
   LI
   LO
   TS
CP0576199
(13S,16S)-N-[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]-2,5,15-trioxo-11-oxa-1,4,14-triazabicyclo[14.3.0]nonadecane-13-carboxamide
   Show/Hide
C25H40N4O7
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0351150
(14S,17S)-N-[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]-2,5,16-trioxo-12-oxa-1,4,15-triazabicyclo[15.3.0]icosane-14-carboxamide
   Show/Hide
C26H42N4O7
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0868641
N-((R)-1-((S)-1-((S)-3-cyclohexyl-1-((R)-2-methyloxiran-2-yl)-1-oxopropan-2-ylamino)-3-(1H-indol-3-yl)-1-oxopropan-2-ylamino)-1-oxopropan-2-yl)-3-methyl-1H-indene-2-carboxamide
   Show/Hide
C37H44N4O5
 1
1
IC50 = 16000 nM
   TI
   LI
   LO
   TS
CP0411613
N-[(2R)-1-[[(2S)-1-[[(2S)-3-cyclohexyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]amino]-3-(4-methoxyphenyl)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]-3-methyl-1H-indene-2-carboxamide
   Show/Hide
C36H45N3O6
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0850423
N-((R)-1-((S)-3-(1H-indol-3-yl)-1-((S)-4-(methylsulfonyl)-1-phenylbut-3-en-2-ylamino)-1-oxopropan-2-ylamino)-1-oxopropan-2-yl)-3-methyl-1H-indene-2-carboxamide
   Show/Hide
C36H38N4O5S
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS